期刊名称：EXPERT OPINION ON DRUG DISCOVERY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.
The Editors welcome:
- Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology
- Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug
- Perspectives on topical issues with potential impact on the future of drug discovery
The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.
Indexing
Chemical Abstracts (CODEN: EODDBX), EMBASE/Excerpta Medica, Science Citation Index Expandedâ„?P>
Instructions to Authors
Guidelines_EODC.pdf
Editorial Board
Commissioning Editor: Joris Roulleau
Production Editor: Sumayya Patel
Editorial Advisory Board
David Clark - Argenta Discovery Ltd., Harlow, England, UK
Dalia Cohen - Rosetta Genomics, North Brunswick, NJ, USA
Mike M Hann - GlaxoSmithKline Medicines, Stevenage, UK
John Hassard - Imperial College, London, England, UK
Kit S Lam - University of California Davis, Sacramento, CA, USA
W Leifert - Commonwealth Scientific and Industrial Research Organisation, Adelaide, Australia
Lorenz Mayr - Novartis Pharma AG, Basel, Switzerland
Nouri Neamati - University of Southern California, Los Angeles, CA, USA
Emanuel F Petricoin - George Mason University, Manassas, VA, USA
Bryn Roberts - Roche, Macclesfield, England, UK
Robert Ruffolo - Wyeth Pharmaceuticals, Collegeville, PA, USA
Alexander Scheer - Serono Pharmaceutical Research Institute, Geneva, Switzerland
Richard K Scott - Amgen, Cambridge, England, UK
Gary Smejkal - Pressure BioSciences Inc., Woburn, MA, USA
Micahel J Sofia - Pharmasset Inc., Princeton, NJ, USA
Roberto Solari - GlaxoSmithKline, Stevenage, England, UK
Alain Stricker-Krongrad - Charles River Laboratories, Worcester, MA, USA
Keith E Suckling - Welwyn Garden City, England, UK
Dirk Ullmann - Evotec OAI, Hamburg, Germany
Robert Williams - Cancer Research UK, London, England, UK
Mark Whittaker - Evotec OAI, Milton Park, England, UK
|
